Acacia Pharma
Cambridge · Founded 2006
About Acacia Pharma
Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $63.5M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2018)
- Ticker: epa:ACPH
- Website: acaciapharma.com
- Phone: +441223875130
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/acacia-pharma-104623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.